| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Laboratory of Cellular Biochemistry, RIKEN, Saitama, Japan;
Laboratory of Nutrition, Azabu University School of Veterinary Medicine, Kanagawa, Japan; and
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202
Activin A, a member of the TGF-β superfamily, is a pluripotent growth and differentiation factor. In this study, we report that murine Th cells produce activin A upon activation. Activin activity in the cultured CD4+ T cells was induced by anti-CD3 cross-linking. Activin βA mRNA level was increased in response to activation, indicating that activin production in CD4+ T cells is regulated at the mRNA level. Activin production was detected exclusively in CD4+CD25– T cells, but not in CD4+CD25+ regulatory T cells. When CD4+ T cells were differentiated into Th cell subsets, higher activin secretion was detected when cultured under Th2-skewing conditions. The mRNA level of activin βA was abundant in Th2, but not in Th1 cells. Furthermore, secretion of activin was significantly higher in activated Th2 clones than in Th1 clones. The activin βA-proximal promoter contains a binding site for c-Maf, a Th2-specific transcriptional factor, at close proximity with an NF-AT binding site. c-Maf was able to synergize with NF-AT to transactivate activin βA gene, and both factors are implicated in activin βA transcription in Th2 cells. Activin A induced macrophages to express arginase-1 (M-2 phenotype), whereas it inhibited inducible NO synthase expression (M-1 phenotype) induced by IFN-
. Taken together, these observations suggest that activin A is a novel Th2 cytokine that promotes differentiation of macrophages toward the M-2 phenotype.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a Grant-in-Aid for Scientific Research (18580300) from Japan Society for the Promotion of Science (to K.O.) and a grant for the Chemical Biology Research Program from The Institute of Physical and Chemical Research.
2 Address correspondence and reprint requests to Dr. Kenji Ogawa, Laboratory of Cellular Biochemistry, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. E-mail address: kkogawa{at}riken.jp
3 Abbreviations used in this paper: iNOS, inducible NO synthase; CsA, cyclosporin A; MARE, Maf recognition element; TGC, thioglycolate.
This article has been cited by other articles:
|
|
 |
|
  Y. Xia and A. L Schneyer The biology of activin: recent advances in structure, regulation and function J. Endocrinol., July 1, 2009; 202(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huber, F. R. Stahl, J. Schrader, S. Luth, K. Presser, A. Carambia, R. A. Flavell, S. Werner, M. Blessing, J. Herkel, et al. Activin A Promotes the TGF-{beta}-Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells J. Immunol., April 15, 2009; 182(8): 4633 - 4640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ogawa, M. Funaba, and M. Tsujimoto A dual role of activin A in regulating immunoglobulin production of B cells J. Leukoc. Biol., June 1, 2008; 83(6): 1451 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Robson, D. J. Phillips, T. McAlpine, A. Shin, S. Svobodova, T. Toy, V. Pillay, N. Kirkpatrick, D. Zanker, K. Wilson, et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production Blood, March 1, 2008; 111(5): 2733 - 2743. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
